Correlation Between Champions Oncology and Enlivex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Enlivex Therapeutics, you can compare the effects of market volatilities on Champions Oncology and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Enlivex Therapeutics.
Diversification Opportunities for Champions Oncology and Enlivex Therapeutics
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Champions and Enlivex is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Champions Oncology i.e., Champions Oncology and Enlivex Therapeutics go up and down completely randomly.
Pair Corralation between Champions Oncology and Enlivex Therapeutics
Given the investment horizon of 90 days Champions Oncology is expected to generate 2.5 times more return on investment than Enlivex Therapeutics. However, Champions Oncology is 2.5 times more volatile than Enlivex Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.3 per unit of risk. If you would invest 974.00 in Champions Oncology on November 4, 2024 and sell it today you would earn a total of 125.00 from holding Champions Oncology or generate 12.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. Enlivex Therapeutics
Performance |
| Timeline |
| Champions Oncology |
| Enlivex Therapeutics |
Champions Oncology and Enlivex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and Enlivex Therapeutics
The main advantage of trading using opposite Champions Oncology and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
| Enlivex Therapeutics vs. Pluri Inc | Enlivex Therapeutics vs. BioLineRx | Enlivex Therapeutics vs. Purple Biotech | Enlivex Therapeutics vs. Histogen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Transaction History View history of all your transactions and understand their impact on performance |